Floatz logo

Alloreactive Nk Cell Infusion

Natural Killer Cell

IRCCS Azienda Ospedaliero-Universitaria di BolognaCell therapyN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Natural Killer Cell cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Alloreactive Nk Cell Infusion is also rated in:

acute myeloid leukemiaDormant
D
Indicative ·
30 / 100
View asset →
Minimal Residual DiseaseDormant
D
Indicative ·
30 / 100
View asset →
acute myeloid leukemiaDormant
D
Indicative ·
26 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →